Navigation Links
Allergan in Medical News

Video: Allergan Announces the LATISSE(TM) Wishes Campaign, Committing $1 Million to The Make-A-Wish Foundation(R)

Register on LATISSE(TM) Web Site to Help Reach Goal IRVINE, Calif., March 27 /PRNewswire-FirstCall/ -- Allergan, Inc. (NYSE: AGN ) hosted a star-studded event last night in Hollywood to launch LATISSE (TM) Wishes , a charitable public awareness campaign designed to help make wishes come...

QLT announces agreement to sell Aczone(R) to Allergan for approximately US$150 million

VANCOUVER, June 9 /PRNewswire-FirstCall/ - QLT Inc. (NASDAQ: QLTI; TSX: QLT) announced today that QLT USA, Inc., its wholly-owned subsidiary, has entered into an asset purchase agreement with Allergan Sales, LLC, a wholly-owned subsidiary of Allergan, Inc. (NYSE: AGN ) to fully divest QLT's w...

Novavax and Allergan Terminate Manufacturing Supply Agreement for Estrasorb

Action allows Novavax to focus on its vaccine business and reduce cash burn ROCKVILLE, Md., Oct. 25 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX ) announced today that it has agreed with Allergan, Inc. to terminate its manufacturing supply agreement for Estrasorb. Estrasorb was previou...

Waging War on Wrinkles: Infini Cosmetic Associates Now Offers Recent FDA Approved Dysport - The Botox Alternative

...agreement with the manufacturer, Ipsen. The addition of Dysport™ to their dermal filler arsenal positions Medic as a threatening opponent to the allergan empire and their line of beauty treatments (Botox® and the Juvederm® - hyaluronic acid gel fillers). BOTOX® Cosmetic is the solution f...

Watson Confirms Filing of Abbreviated New Drug Application for Generic Sanctura XR(R)

...on's trospium chloride extended-release capsules are the generic version of allergan Inc.'s Sanctura XR((R))( )product, which is indicated for the treatment of ...ptoms of urge urinary incontinence, urgency and urinary frequency. allergan filed suit against Watson on July 13, 2009 in the U.S. District Court for t...

Coapt Systems, Inc. Launches Hydrelle(TM) a New, FDA-Approved Dermal Filler with Lidocaine for Significant Wrinkle Correction and Greater Patient Comfort

...eater patient comfort. Proven safe and effective, Hydrelle is also a financially attractive alternative to traditional fillers such as Juvederm(R) by allergan Medical, and Restylane(R) by Medicis Pharmaceutical. Hydrelle has been specifically formulated to deliver rapid results comparable to other hyalu...

Infini Cosmetic Associates Offers Boomer Stimulus Packages to Offset Aging and Help Job Seekers Get a Fresh Start

... to 4 months. Individual results may vary. BOTOX® has gained significant popularity in recent years. As a National Educator for Botox Cosmetic and allergan Corp.(the makers of Botox®), Dr. Hall teaches physicians from all over the country. Dr. Hall has performed more than 5000 injections over the last...

Dr. Daniel Ronel Offers New Permanent Lip Enhancement in New Mexico

...Research Council of America. Because of his combined expertise in pediatrics and plastic surgery, Dr. Ronel is one of 13 national experts selected by allergan to sit on the Breast Implant Research Team, an advisory panel on silicone breast implants. Additionally, Dr. Ronel is a member of the Radiesse Medica...

Digirad Names Two Veteran Healthcare Executives to Board

...Laboratories in 1998. Mr. Malchow has also held executive positions at allergan and American Hospital Supply. At allergan he held several positions including Corporate Operating Committee Member, V...

SkinMedica to Co-Promote ACZONE(R) (dapsone) Gel 5% to Pediatricians in the U.S.

... it has entered into a co-promotion agreement with allergan for ACZONE(R) (dapsone) Gel 5%, a first-in-class ...physicians and patients across the country." allergan will continue to distribute the product, and its d... sales force will continue to promote the product. allergan will book all ACZONE(R) Gel 5% sales and SkinMedic...
Allergan in Medical Technology

ExonHit Therapeutics Expands Strategic Collaboration With Allergan

PARIS, France, January 6 /PRNewswire-FirstCall/ -- - Early Renewal of the Agreement to Extend the Collaboration Until December 2011 - Expansion of the Scope of the Collaboration to Include Antibody Discovery in Ophthalmology - Revised Commercial Terms and Payments to ExonH...

Fort Worth Surgeon Chosen as Investigator in Clinical Trial for Weight-Loss Device

...xas, Feb. 20 /PRNewswire/ -- Adam B. Smith, D.O., FACOS, of Fort Worth LAP-BAND(R) is one of two surgeons in the Dallas/Fort Worth metroplex chosen by allergan Medical for "A Research Study of BioEnterics(R) Intragastric Balloon (BIB) System to Assist in the Weight Management of Obese Subjects," a clinical tr...

Novavax Reports Third Quarter 2007 Financial Results and Progress with Vaccine Development Programs

...l supplies of our VLP vaccine candidates. -- Announced in conjunction with allergan the wind down of manufacturing of the production of Estrasorb (R). Estrasorb (R) was acquired by allergan as a result of their acquisition of Esprit Pharma in October 2007. Som...
Allergan in Biological Technology

Video: Allergan Announces U.S. Food and Drug Administration (FDA) Approval of Latisse(TM) -- First and Only Treatment Approved by the FDA for Hypotrichosis of Eyelashes

New Prescription Product Increases Length, Thickness and Darkness of Eyelashes IRVINE, Calif., Dec. 26 /PRNewswire-FirstCall/ -- Allergan, Inc. (NYSE: AGN ) today announced the U.S. Food and Drug Administration (FDA) has approved LATISSE(TM) (bimatoprost ophthalmic solution) 0.03% as a nove...

Indevus Announces Allergan as New Partner for SANCTURA Brand

Company Enters Into License, Commercialization and Supply Agreement Company to Host Conference Call at 12:30 p.m. Eastern Time, September 19, 2007 LEXINGTON, Mass., Sept. 19 /PRNewswire-FirstCall/ -- Indevus Pharmaceuticals, Inc. (Nasdaq: IDEV ) today annou...

ExonHit Therapeutics: Allergan and ExonHit's First Collaboration Compound to Begin Human Clinical Trials

PARIS, August 28 /PRNewswire-FirstCall/ -- ExonHit Therapeutics, a drug and diagnostic discovery company, today announced that its drug discovery collaboration with Allergan Inc. (NYSE: AGN ), a global speciality pharmaceutical and medical device company, has reached a success milestone. As a...

Seasoned Dermatologist Nissan Pilest of Irvine, CA, Joins SDS Clinical Trials as Clinical Investigator for Dermatology Division

...on their full line of lasers including the top tiered GentleMax laser. Dr. Pilest also trains other physicians in the advanced injection techniques of allergan products Juvederm and Botox, is on the Medical Education Faculty for Bioform's Radiesse long term dermal filler and also is a physician trainer for Re...

Dr. Daniel Ronel Selects Artefill to Meet Growing Patient Demand for a Longer Lasting Dermal Filler

...Research Council of America. Because of his combined expertise in pediatrics and plastic surgery, Dr. Ronel is one of 13 national experts selected by allergan to sit on the Breast Implant Research Team, an advisory panel on silicone breast implants. Dr. Ronel is a member of the Radiesse Medical Education Fa...

WuXi AppTec Welcomes Three Senior Professionals

...brings more than 30 years of rich experiences in preclinical safety assessment and drug development. Dr. Yuan had worked previously in Upjohn, Pfizer, allergan and Vitae Pharmaceutical. Dr. Yuan received a D.V.M. from National Taiwan University and a Ph.D. in Veterinary Pathology from Cornell University . ...

ExonHit Therapeutics Invested Strongly in 2008 for Pivotal 2009 Results

... - Expansion of the strategic collaboration with allergan and extension until end 2011 2008 Key e...estone payment in our strategic collaboration with allergan in addition to the annual R&D payments. ... EHT/AGN 0001, the most advanced compound of the allergan collaboration, continues to make progress and is e...

Beacon Equity Issues Technical Trade Alerts on Drug Manufacturer Stocks: FRX, TEVA, AGN, CEPH, VRTX, ADLR

...eaconEquity.com/m Today's Trade Alerts include: Forest Laboratories Inc. (NYSE: FRX ), Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA ), allergan Inc. (NYSE: AGN ), Cephalon Inc. (Nasdaq: CEPH ), Vertex Pharmaceuticals Inc. (Nasdaq: VRTX ) and Adolor Corp. (Nasdaq: ADLR ). Join th...

David Bagley Joins Histogen as President

...multiple critical diseases, wound care and aesthetic product applications. Most recently, Bagley served as Vice President and General Manager for allergan Medical, Inc. with a focus on operations, technology, global distribution, quality and business disciplines. Prior to this, he held positions with Smi...

MultiVu Video Feed: U.S Food and Drug Administration (Fda) Approves Latisse(TM) --

...o dispensing a prescription medical product. Based on today's FDA approval, allergan expects to launch the product nationwide in the first quarter of 2009. Doct... * Frederick Beddingfield, III, MD, PhD, Chief Medical Officer for allergan Medical and Vice President and Therapeutic Area Head for Dermatology ...
Other Tags
(Date:8/22/2014)... Vegas, NV (PRWEB) August 22, 2014 ... that uses university-proven research to show people how they can ... lean muscle in only a matter of weeks has caught ... , “Ben Pakulski is one of the most well-known bodybuilders ... get the body he has today, that in itself is ...
(Date:8/22/2014)... a complex autoimmune disease that affects 1 to ... only cope with pain, disability and joint disfigurements, ... family life and marital functioning. While many pharmacological ... disability is common. In addition, some patients avoid ... side effects. Because of this, there is interest ...
(Date:8/22/2014)... 2014 Testosterone treatment lawsuits ( ... courts on behalf of men who allegedly suffered ... prescription low testosterone therapies, Bernstein Liebhard LLP reports. ... filed against Pfizer Inc. on July 31st by ... issues due to his use of Depo-Testosterone. (Case ...
(Date:8/22/2014)... UK (PRWEB) August 22, 2014 The ... recent past, specifically in the developing world, has led ... and the number of deaths due to AIDS globally. ... declining, the number of new patients becoming affected by ... conscious efforts being undertaken by all related organisations and ...
(Date:8/22/2014)... Ohio (PRWEB) August 22, 2014 Dayton Children's ... care tower as part of a $141 million campus renewal. ... patient care tower were unveiled to the public. , ... facilities plan that will create a campus that meets the ... future. These new care spaces will embody Dayton Children’s unique ...
Breaking Medicine News(10 mins):Health News:Mi40x: Review Exposes Ben Pakulski’s Guide to Packing on Lean Muscle Fast 2Health News:Study shows cognitive-behavioral coping skills training has positive effects on rheumatoid arthritis 2Health News:Testosterone Treatment Lawsuit News: New Filing Alleges Depo-Testosterone Caused Life-Threatening Heart Problems, Bernstein Liebhard LLP reports. 2Health News:Testosterone Treatment Lawsuit News: New Filing Alleges Depo-Testosterone Caused Life-Threatening Heart Problems, Bernstein Liebhard LLP reports. 3Health News:Testosterone Treatment Lawsuit News: New Filing Alleges Depo-Testosterone Caused Life-Threatening Heart Problems, Bernstein Liebhard LLP reports. 4Health News:Worldwide HIV Infection Drug Market Examined in New Kuick Research Report Published at MarketPublishers.com 2Health News:Worldwide HIV Infection Drug Market Examined in New Kuick Research Report Published at MarketPublishers.com 3Health News:Dayton Children's Hospital Breaks Ground on New, Eight-story Patient Care Tower 2Health News:Dayton Children's Hospital Breaks Ground on New, Eight-story Patient Care Tower 3Health News:Dayton Children's Hospital Breaks Ground on New, Eight-story Patient Care Tower 4Health News:Dayton Children's Hospital Breaks Ground on New, Eight-story Patient Care Tower 5
(Date:8/22/2014)... Calif. Thomson Reuters , a leading source ... researchers at the University of California, Riverside in its ... minds of our times." , To generate the list, ... to identify researchers whose published work has had enormous ... among some 3,200 individuals who published the greatest number ...
(Date:8/22/2014)... Research presented at the 29th Annual International ... by Hera Therapeutics Inc. combats three types of ... percent of all cervical cancer. , When tested ... the replication of HPV-16, HPV-18 and HPV-11 cells, ... Broker, Ph.D., who presented the findings at the ...
(Date:8/22/2014)... is available in French . ... essential nutrients from African soils looming as a major threat ... today finds that over the last five years, 1.7 million ... have rejuvenated 1.6 million hectares and helped them double or ... for a Green Revolution in Africa (AGRA) focuses on intensive ...
Breaking Biology News(10 mins):5 UC Riverside scientists among world's most influential scientific minds 2Effort to confront Africa's soil health crisis helps millions of farmers triple yields 2Effort to confront Africa's soil health crisis helps millions of farmers triple yields 3Effort to confront Africa's soil health crisis helps millions of farmers triple yields 4
Other Contents